MX2021005451A - Agente activador de adipocitos pardos y beige que contiene d-alulosa como ingrediente activo. - Google Patents

Agente activador de adipocitos pardos y beige que contiene d-alulosa como ingrediente activo.

Info

Publication number
MX2021005451A
MX2021005451A MX2021005451A MX2021005451A MX2021005451A MX 2021005451 A MX2021005451 A MX 2021005451A MX 2021005451 A MX2021005451 A MX 2021005451A MX 2021005451 A MX2021005451 A MX 2021005451A MX 2021005451 A MX2021005451 A MX 2021005451A
Authority
MX
Mexico
Prior art keywords
brown
allulose
active ingredient
beige adipocyte
agent containing
Prior art date
Application number
MX2021005451A
Other languages
English (en)
Inventor
Ken Izumori
Akihide Yoshihara
Koji Murao
Hitomi Imachi
Original Assignee
Univ Kagawa Nat Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kagawa Nat Univ Corp filed Critical Univ Kagawa Nat Univ Corp
Publication of MX2021005451A publication Critical patent/MX2021005451A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pediatric Medicine (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se proporciona un agente activador de adipocitos pardos y beige y un alimento activador de adipocitos pardos y beige, cada uno de los cuales contiene D-alulosa como un ingrediente activo. Se proporcionan un agente activador de adipocitos a pardos y beige que contiene D-alulosa como un ingrediente activo; un agente activador de adipocitos pardos y beige que contiene al menos D-alulosa y que tiene una acción promotora de la expresión de UCP-1; un agente activador de adipocitos pardos y beige el cual aumenta la expresión de UCP-1 y por lo tanto, activa los adipocitos pardos y beige; un agente promotor del consumo de energía que contiene D-alulosa como un ingrediente activo; un agente promotor del consumo de energía el cual activa los adipocitos de pardos y beige y por lo tanto, promueve el consumo de energía; un agente que aumenta la expresión de UCP-1 que contiene D-alulosa como un ingrediente activo; y una composición o composición de alimento que contiene esos agentes.
MX2021005451A 2018-11-08 2019-11-07 Agente activador de adipocitos pardos y beige que contiene d-alulosa como ingrediente activo. MX2021005451A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018210262 2018-11-08
PCT/JP2019/043703 WO2020096002A1 (ja) 2018-11-08 2019-11-07 Ｄ－アルロースを有効成分とする褐色脂肪・ベージュ脂肪細胞活性化剤

Publications (1)

Publication Number Publication Date
MX2021005451A true MX2021005451A (es) 2021-06-18

Family

ID=70611530

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005451A MX2021005451A (es) 2018-11-08 2019-11-07 Agente activador de adipocitos pardos y beige que contiene d-alulosa como ingrediente activo.

Country Status (7)

Country Link
US (1) US20210386767A1 (es)
EP (1) EP3878457A4 (es)
JP (2) JPWO2020096002A1 (es)
KR (1) KR20210091211A (es)
CN (1) CN113015533A (es)
MX (1) MX2021005451A (es)
WO (1) WO2020096002A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102365290B (zh) 2009-03-30 2014-12-31 松谷化学工业株式会社 与含有规定量目标己糖的原料糖不同的糖组成的糖组合物制造方法以及所制造的糖组合物的用途
JP6099870B2 (ja) * 2012-01-06 2017-03-22 松谷化学工業株式会社 スクロースとｄ−プシコースを含む新規甘味料
KR102303570B1 (ko) * 2013-04-26 2021-09-16 마쓰다니가가꾸고오교가부시끼가이샤 에너지 소비의 촉진 및/또는 에너지 소비 기능 저하의 치료 및/또는 예방제, 또는 방법
EP2843044A1 (en) * 2013-09-03 2015-03-04 Roquette Frères Improved variant of D-psicose 3-epimerase and uses thereof
WO2016004093A2 (en) * 2014-07-01 2016-01-07 Stealth Biotherapeutics Corp Therapeutic compositions including galectin-3 inhibitors and uses thereof
KR101692033B1 (ko) * 2015-09-01 2017-01-03 경북대학교 산학협력단 Ｄ-싸이코스를 유효성분으로 함유하는 지질 관련 대사성 질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
CN113015533A (zh) 2021-06-22
KR20210091211A (ko) 2021-07-21
EP3878457A4 (en) 2022-07-27
US20210386767A1 (en) 2021-12-16
JPWO2020096002A1 (ja) 2021-12-09
JP2024032817A (ja) 2024-03-12
WO2020096002A1 (ja) 2020-05-14
EP3878457A1 (en) 2021-09-15

Similar Documents

Publication Publication Date Title
ECSP12012349A (es) Agentes inductores de apoptosis contra el cáncer y de enfermedades inmunes y autoinmunes
ECSP12012348A (es) Agentes inductores de apoptosis contra el cáncer y de enfermedades inmunes y autoinmunes
PH12016500372A1 (en) Pharmaceutical composition containing pyrimidine compound as active ingredient
PH12021550187A1 (en) Pyrrolopyrimidine itk inhibitors
MA40437A (fr) Méthodes de traitement du cancer faisant appel à des inhibiteurs de tigit et à des agents anticancéreux
BR112017015864A2 (pt) compostos e métodos para modular a expressão de tmprss6
BR112015013123A2 (pt) inibidores de beta-lactamase
CR20140421A (es) Cepa plaguicida de flavobacterium y composiciones bioactivas, metabolitos y usos de la misma
MX2019002335A (es) Uso de hidrolizado de colageno para mejorar el rendimiento de resistencia y para estimular el catabolismo lipidico.
BRPI0513466A (pt) antivìrus natural e composição compreendendo o mesmo
BR112015023203A2 (pt) métodos para tratamento de câncer, para aumentar a eficiência de um tratamento de câncer, para retardar e/ou prevenir o desenvolvimento de câncer, para tratar um indivíduo com câncer, para aumentar a sensibilidade para um agente de terapia para câncer, para estender um período de sensibilidade e para estender a duração da resposta para uma terapia para câncer, e usos
MX2018005796A (es) Reduccion de la sensacion de picazon en la piel.
ZA202203775B (en) Substituted cyanopyrrolidines with activity as usp30 inhibitors
TW201614069A (en) Inhibitors of MYH7B and uses thereof
UY4759S (es) Modelo industrial de cuerpo de extintor de incendios
MX2016015092A (es) Inhibidor de proliferacion de celulas madre cancerosas.
MX2012008890A (es) Composicion de combinacion, que comrpende como ingrediente activo l-carnitina o propionil l-carnitina, para la prevencion o tratamiento de insuficiencia venosa cronica.
WO2021046315A3 (en) Inhibitors of encephalitic alphaviruses
MX2017015418A (es) Composiciones y metodos de uso de beta-hidroxi-beta-metilbutirato (hmb) para reducir grasa corporal.
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
PH12020500055A1 (en) A personal care composition
JOP20210008A1 (ar) أنواع أبيراز مذابة، وطرق لاستخدامها
TN2019000037A1 (en) Use of collagen hydrolysate for improving endurance performance and for stimulating lipocatabolism
MX2021005451A (es) Agente activador de adipocitos pardos y beige que contiene d-alulosa como ingrediente activo.
BR112021011293A2 (pt) Composição farmacêutica para prevenção ou tratamento de câncer compreendendo lactobacillus sakei wikim30 como ingrediente ativo